The cradle of globally recognized creative biotechnology

HYUNDAI BIOSCIENCE’s research & innovation center has continuously produced globally recognized research results with the commercialization of LDH based on Organic-Inorganic Hybrid technology. Based on the long accumulated research know-how, HYUNDAI BIOSCIENCE is the only company commercialized new DDS (Drug Delivery System) using LDH Platform Technology.

Through application of LDH Platform Technology, our research & innovation center has developed a variety of DDS commercialization techniques such as oral, dermal and injection. We hold various patents for these techniques and materials both domestically and internationally.